Similar to OX40, 4-1BB is a co-stimulatory receptor expressed on T cells and antigen-presenting cells, and 4-1BB agonists enhance the anti-tumor effector functions of cytotoxic T cells (54). Here, TNFRSF9 is linked to neoplasm.